← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #844 OF 1,000 MOST-CITED

Procedure for nonconforming product not documented

FDA cited this observation 18 times across 18 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Devices18
BY FISCAL YEAR
FY202618

How FDA worded it — real examples

Procedures to define the controls and related responsibilities and authorities for the identification, documentation, segregation, evaluation, and disposition of nonconforming product were not documented.

Marine Polymer Technologies · Topsfield, Massachusetts · Devices · 2026-07-06

Procedures to define the controls and related responsibilities and authorities for the identification, documentation, segregation, evaluation, and disposition of nonconforming product were not documented.

West Medical Supplies · Hallandale Beach, Florida · Devices · 2026-05-26

Procedures to define the controls and related responsibilities and authorities for the identification, documentation, segregation, evaluation, and disposition of nonconforming product were not documented.

Light Age, Inc. · Somerset, New Jersey · Devices · 2026-05-15

Procedures to define the controls and related responsibilities and authorities for the identification, documentation, segregation, evaluation, and disposition of nonconforming product were not adequately documented.

Biopoly Llc · Fort Wayne, Indiana · Devices · 2026-04-30

Procedures to define the controls and related responsibilities and authorities for the identification, documentation, segregation, evaluation, and disposition of nonconforming product were not adequately documented.

EVOLUTION DEVICES, INC · San Francisco, California · Devices · 2026-04-15

Procedures to define the controls and related responsibilities and authorities for the identification, documentation, segregation, evaluation, and disposition of nonconforming product were not adequately documented.

All Quality & Services, Inc. · Fremont, California · Devices · 2026-04-10

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Quality risk managementPharmaceutical quality systemMedical devices

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →